Latest Arovella Therapeutics (ASX:ALA) News
Page 1
Page 1 of 3
Healthcare Wrap - Week 44 (26 Oct -> 30 Oct) 2026
31 Oct 2026
Arovella doses first patient in ALA-101 blood cancer trial
27 Oct 2026
Healthcare Wrap - Week 43 (19 Oct -> 23 Oct) 2026
24 Oct 2026
Arovella reaches dosing threshold as ALA-101 trial enters human testing
23 Oct 2026
Arovella secures $4.03 million refund as ALA-101 trial approaches first dosing
22 Oct 2026
Healthcare Wrap - Week 41 (5 Oct -> 9 Oct) 2026
10 Oct 2026
Arovella’s second ALA-101 batch clears the way for Phase 1 expansion
7 Oct 2026
Market Wrap - Week 37 (7 Sept -> 11 Sept) 2026
12 Sept 2026
Healthcare Wrap - Week 37 (7 Sept -> 11 Sept) 2026
12 Sept 2026
Arovella Advances with First Clinical Batch of ALA-101 and Trial Site Activation
7 Sept 2026
Healthcare Wrap - Week 31 (27 July -> 31 July) 2026
1 Aug 2026
Arovella Advances CAR-iNKT Trials with $14.4 Million Cash Backing
27 July 2026